Literature DB >> 11898696

SSRI sexual dysfunction: a female perspective.

Paula L Hensley1, H George Nurnberg.   

Abstract

Women experience two to three times the rate of depression that men do. Selective serotonin reuptake inhibitors (SSRIs) are prescribed for many conditions other than depression, such as anxiety disorders, premenstrual dysphoric disorder, pain syndromes, impulse control disorders, and personality disorders, some of which are more common in women. Increasing awareness of sexual side effects has tempered the initial enthusiasm with which SSRIs were greeted. Men taking SSRIs report higher rates of sexual side effects than women taking them, however, women seem to experience more severe sexual dysfunction. In this article, we discuss the epidemiology of sexual dysfunction and describe treatments with sildenafil.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11898696     DOI: 10.1080/00926230252851267

Source DB:  PubMed          Journal:  J Sex Marital Ther        ISSN: 0092-623X


  5 in total

1.  An experimental test of the ovulatory homolog model of female orgasm.

Authors:  Mihaela Pavlicev; Andreja Moset Zupan; Amanda Barry; Savannah Walters; Kristin M Milano; Harvey J Kliman; Günter P Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

2.  Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial.

Authors:  Amirhossein Modabbernia; Hamid Sohrabi; Abbas-Ali Nasehi; Firoozeh Raisi; Sepideh Saroukhani; Amirhossein Jamshidi; Mina Tabrizi; Mandana Ashrafi; Shahin Akhondzadeh
Journal:  Psychopharmacology (Berl)       Date:  2012-05-03       Impact factor: 4.530

3.  Sexual assault in the military and its impact on sexual satisfaction in women veterans: a proposed model.

Authors:  Jennifer S McCall-Hosenfeld; Jane M Liebschutz; Avron Spiro; Margaret R Seaver
Journal:  J Womens Health (Larchmt)       Date:  2009-06       Impact factor: 2.681

4.  Correlates of sexual satisfaction among sexually active postmenopausal women in the Women's Health Initiative-Observational Study.

Authors:  Jennifer S McCall-Hosenfeld; Sarah A Jaramillo; Claudine Legault; Karen M Freund; Barbara B Cochrane; Joann E Manson; Nanette K Wenger; Charles B Eaton; Beatriz L Rodriguez; S Gene McNeeley; Denise Bonds
Journal:  J Gen Intern Med       Date:  2008-10-07       Impact factor: 5.128

5.  Crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial.

Authors:  Ladan Kashani; Sahar Aslzadeh; Kamyar Shokraee; Ahmad Shamabadi; Borna Tadayon Najafabadi; Morteza Jafarinia; Sophia Esalatmanesh; Shahin Akhondzadeh
Journal:  Avicenna J Phytomed       Date:  2022 May-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.